vs

Side-by-side financial comparison of Organon & Co. (OGN) and Williams-Sonoma, Inc. (WSM). Click either name above to swap in a different company.

Williams-Sonoma, Inc. is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.2× Organon & Co.). Williams-Sonoma, Inc. runs the higher net margin — 12.8% vs -13.6%, a 26.4% gap on every dollar of revenue. On growth, Williams-Sonoma, Inc. posted the faster year-over-year revenue change (4.6% vs -5.3%). Williams-Sonoma, Inc. produced more free cash flow last quarter ($248.1M vs $96.0M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -9.1%).

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

Williams Sonoma is an American retailer of cookware, appliances, and home furnishings. It is owned by Williams-Sonoma, Inc., and was founded by Charles E. (Chuck) Williams in 1956.

OGN vs WSM — Head-to-Head

Bigger by revenue
WSM
WSM
1.2× larger
WSM
$1.9B
$1.5B
OGN
Growing faster (revenue YoY)
WSM
WSM
+9.9% gap
WSM
4.6%
-5.3%
OGN
Higher net margin
WSM
WSM
26.4% more per $
WSM
12.8%
-13.6%
OGN
More free cash flow
WSM
WSM
$152.1M more FCF
WSM
$248.1M
$96.0M
OGN
Faster 2-yr revenue CAGR
OGN
OGN
Annualised
OGN
-3.6%
-9.1%
WSM

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
OGN
OGN
WSM
WSM
Revenue
$1.5B
$1.9B
Net Profit
$-205.0M
$241.6M
Gross Margin
49.2%
46.1%
Operating Margin
-9.8%
17.0%
Net Margin
-13.6%
12.8%
Revenue YoY
-5.3%
4.6%
Net Profit YoY
-288.1%
-3.0%
EPS (diluted)
$-0.78
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OGN
OGN
WSM
WSM
Q4 25
$1.5B
$1.9B
Q3 25
$1.6B
$1.8B
Q2 25
$1.6B
$1.7B
Q1 25
$1.5B
$2.5B
Q4 24
$1.6B
$1.8B
Q3 24
$1.6B
$1.8B
Q2 24
$1.6B
$1.7B
Q1 24
$1.6B
$2.3B
Net Profit
OGN
OGN
WSM
WSM
Q4 25
$-205.0M
$241.6M
Q3 25
$160.0M
$247.6M
Q2 25
$145.0M
$231.3M
Q1 25
$87.0M
$384.9M
Q4 24
$109.0M
$249.0M
Q3 24
$359.0M
$225.7M
Q2 24
$195.0M
$265.7M
Q1 24
$201.0M
$354.4M
Gross Margin
OGN
OGN
WSM
WSM
Q4 25
49.2%
46.1%
Q3 25
53.5%
47.1%
Q2 25
54.8%
44.3%
Q1 25
55.6%
45.2%
Q4 24
56.3%
46.7%
Q3 24
58.3%
46.2%
Q2 24
58.4%
48.3%
Q1 24
59.0%
46.0%
Operating Margin
OGN
OGN
WSM
WSM
Q4 25
-9.8%
17.0%
Q3 25
15.2%
17.9%
Q2 25
14.4%
16.8%
Q1 25
6.7%
20.1%
Q4 24
8.1%
17.8%
Q3 24
13.1%
16.2%
Q2 24
14.6%
19.5%
Q1 24
14.5%
20.1%
Net Margin
OGN
OGN
WSM
WSM
Q4 25
-13.6%
12.8%
Q3 25
10.0%
13.5%
Q2 25
9.1%
13.4%
Q1 25
5.8%
15.6%
Q4 24
6.8%
13.8%
Q3 24
22.7%
12.6%
Q2 24
12.1%
16.0%
Q1 24
12.4%
15.6%
EPS (diluted)
OGN
OGN
WSM
WSM
Q4 25
$-0.78
$1.96
Q3 25
$0.61
$2.00
Q2 25
$0.56
$1.85
Q1 25
$0.33
$1.02
Q4 24
$0.42
$1.96
Q3 24
$1.38
$1.74
Q2 24
$0.75
$4.07
Q1 24
$0.78
$5.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OGN
OGN
WSM
WSM
Cash + ST InvestmentsLiquidity on hand
$574.0M
$884.7M
Total DebtLower is stronger
$8.6B
Stockholders' EquityBook value
$752.0M
$2.1B
Total Assets
$12.9B
$5.3B
Debt / EquityLower = less leverage
11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OGN
OGN
WSM
WSM
Q4 25
$574.0M
$884.7M
Q3 25
$672.0M
$985.8M
Q2 25
$599.0M
$1.0B
Q1 25
$547.0M
$1.2B
Q4 24
$675.0M
$826.8M
Q3 24
$763.0M
$1.3B
Q2 24
$704.0M
$1.3B
Q1 24
$575.0M
$1.3B
Total Debt
OGN
OGN
WSM
WSM
Q4 25
$8.6B
Q3 25
$8.8B
Q2 25
$8.9B
Q1 25
$9.0B
Q4 24
$8.9B
Q3 24
$8.7B
Q2 24
$8.7B
Q1 24
$8.7B
Stockholders' Equity
OGN
OGN
WSM
WSM
Q4 25
$752.0M
$2.1B
Q3 25
$906.0M
$2.1B
Q2 25
$733.0M
$2.2B
Q1 25
$542.0M
$2.1B
Q4 24
$472.0M
$1.9B
Q3 24
$493.0M
$2.3B
Q2 24
$144.0M
$2.2B
Q1 24
$48.0M
$2.1B
Total Assets
OGN
OGN
WSM
WSM
Q4 25
$12.9B
$5.3B
Q3 25
$13.6B
$5.2B
Q2 25
$13.5B
$5.2B
Q1 25
$13.2B
$5.3B
Q4 24
$13.1B
$5.0B
Q3 24
$12.8B
$5.2B
Q2 24
$12.2B
$5.2B
Q1 24
$11.9B
$5.3B
Debt / Equity
OGN
OGN
WSM
WSM
Q4 25
11.49×
Q3 25
9.74×
Q2 25
12.14×
Q1 25
16.52×
Q4 24
18.81×
Q3 24
17.75×
Q2 24
60.11×
Q1 24
181.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OGN
OGN
WSM
WSM
Operating Cash FlowLast quarter
$141.0M
$316.3M
Free Cash FlowOCF − Capex
$96.0M
$248.1M
FCF MarginFCF / Revenue
6.4%
13.2%
Capex IntensityCapex / Revenue
3.0%
3.6%
Cash ConversionOCF / Net Profit
1.31×
TTM Free Cash FlowTrailing 4 quarters
$538.0M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OGN
OGN
WSM
WSM
Q4 25
$141.0M
$316.3M
Q3 25
$264.0M
$282.7M
Q2 25
$220.0M
$118.9M
Q1 25
$75.0M
$633.5M
Q4 24
$390.0M
$253.5M
Q3 24
$141.0M
$246.5M
Q2 24
$332.0M
$226.8M
Q1 24
$76.0M
$674.9M
Free Cash Flow
OGN
OGN
WSM
WSM
Q4 25
$96.0M
$248.1M
Q3 25
$218.0M
$230.7M
Q2 25
$181.0M
$60.7M
Q1 25
$43.0M
$566.3M
Q4 24
$335.0M
$170.1M
Q3 24
$99.0M
$215.1M
Q2 24
$300.0M
$187.3M
Q1 24
$30.0M
$621.2M
FCF Margin
OGN
OGN
WSM
WSM
Q4 25
6.4%
13.2%
Q3 25
13.6%
12.6%
Q2 25
11.4%
3.5%
Q1 25
2.8%
23.0%
Q4 24
21.0%
9.4%
Q3 24
6.3%
12.0%
Q2 24
18.7%
11.3%
Q1 24
1.8%
27.3%
Capex Intensity
OGN
OGN
WSM
WSM
Q4 25
3.0%
3.6%
Q3 25
2.9%
2.8%
Q2 25
2.4%
3.4%
Q1 25
2.1%
2.7%
Q4 24
3.5%
4.6%
Q3 24
2.7%
1.8%
Q2 24
2.0%
2.4%
Q1 24
2.8%
2.4%
Cash Conversion
OGN
OGN
WSM
WSM
Q4 25
1.31×
Q3 25
1.65×
1.14×
Q2 25
1.52×
0.51×
Q1 25
0.86×
1.65×
Q4 24
3.58×
1.02×
Q3 24
0.39×
1.09×
Q2 24
1.70×
0.85×
Q1 24
0.38×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons